المؤلفون: Joris, S, Denys, H, Collignon, J, Rasschaert, M, de Roodenbeke, DT, Duhoux, FP, Canon, JL, Tejpar, S, MEBIS, Jeroen, Decoster, L, Aftimos, P, De Grève, J

المساهمون: Joris, S, Denys, H, Collignon, J, Rasschaert, M, de Roodenbeke, DT, Duhoux, FP, Canon, JL, Tejpar, S, MEBIS, Jeroen, Decoster, L, Aftimos, P, De Grève, J

مصطلحات موضوعية: agnostic NGS, olaparib, colorectal cancer, parathyroid cancer, biliary tract cancer, BRCA1, BRCA2, CHEK2, ATM

وصف الملف: application/pdf

العلاقة: ESMO Open, 8 (6) (Art N° 102041); http://hdl.handle.net/1942/43150Test; 001113986700001

الإتاحة: https://doi.org/10.1016/j.esmoop.2023.102041Test
http://hdl.handle.net/1942/43150Test

المؤلفون: Izci H, Macq G, Tambuyzer T, De Schutter H, Wildiers H, Duhoux FP, de Azambuja E, Taylor D, Staelens G, Orye G, Hlavata Z, Hellemans H, De Rop C, Neven P, Verdoodt F

المصدر: Clinical Epidemiology, Vol Volume 15, Pp 559-568 (2023)

مصطلحات موضوعية: machine learning, breast cancer, distant metastases, recurrences, algorithm, administrative data, Infectious and parasitic diseases, RC109-216

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/machine-learning-algorithm-to-estimate-distant-breast-cancer-recurrenc-peer-reviewed-fulltext-article-CLEPTest; https://doaj.org/toc/1179-1349Test

الوصول الحر: https://doaj.org/article/a45b40a659244509b06f4b8491ebfcafTest

المؤلفون: Ong, WL, Schouwenburg, MG, van Bommel, ACM, Stowell, C, Allison, KH, Benn, KE, Browne, JP, Cooter, RD, Delaney, GP, Duhoux, FP, Ganz, PA, Hancock, P, Jagsi, R, Knaul, FM, Knip, AM, Koppert, LB, Kuerer, H, McLaughin, S, Mureau, MAM, Partridge, AH, Reid, DP, Sheeran, L, Smith, TJ, Stoutjesdijk, MJ, Peeters, MJTFDV, Wengstrom, Y, Yip, CH, Saunders, C

المصدر: JAMA oncology. 3(5):677-685

مصطلحات موضوعية: Medicin och hälsovetenskap

الوصول الحر: http://kipublications.ki.se/Default.aspx?queryparsed=id:135849653Test

المؤلفون: Rediti, M, Punie, K, de Azambuja, E, Naert, E, Taylor, Donatienne, Duhoux, FP, Denys, H, Awada, A, Wildiers, H, Ignatiadis, M

المساهمون: UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Service d'oncologie médicale

المصدر: Belgian Journal of Medical Oncology, Vol. 14, no.7, p. 333-338 (2021)

مصطلحات موضوعية: advanced, BRCA, immunotherapy, metastatic, triple-negative breast cancer

العلاقة: boreal:243846; http://hdl.handle.net/2078.1/243846Test; urn:ISSN:1784-7141

الإتاحة: http://hdl.handle.net/2078.1/243846Test

المؤلفون: Wildiers, H, Armstrong, Anne, Cuypere, E, Dalenc, F, Dirix, L, Chan, S, Marme, F, Schröder, CP, Huober, J, Duhoux, FP, Vuylsteke, P, Jager, A, Brain, E, Kuemmel, S, Pápai, Z, Menke-van der Houven van Oordt, CW, Perjesi, L, Mueller, C, Brignone, C, Triebel, F

المساهمون: Christie Hospital NHS Trust, Manchester, United Kingdom.

العلاقة: https://dx.doi.org/10.1158/1078-0432.ccr-23-1173Test; Wildiers H, Armstrong A, Cuypere E, Dalenc F, Dirix L, Chan S, et al. Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase 2b Trial. Clinical cancer research : an official journal of the American Association for Cancer Research. 2023 Nov 8. PubMed PMID: 37939105. Epub 2023/11/08. eng.; http://hdl.handle.net/10541/626748Test; Clinical Cancer Research

الإتاحة: https://doi.org/10.1158/1078-0432.ccr-23-1173Test
http://hdl.handle.net/10541/626748Test

المؤلفون: Agostinetto, E, Nader-Marta, G, Paesmans, M, Ameye, L, Veys, I, Buisseret, L, Neven, P, Taylor, D, Fontaine, C, Duhoux, FP, Canon, JL, Denys, Hannelore, Coussy, F, Chakiba, C, Ribeiro, JM, Piccart, M, Desmedt, C, Ignatiadis, M, Aftimos, P

المصدر: FUTURE ONCOLOGY ; ISSN: 1479-6694 ; ISSN: 1744-8301

مصطلحات موضوعية: Medicine and Health Sciences, ROS1, neoadjuvant, lobular, entrectinib, breast cancer

وصف الملف: application/pdf

العلاقة: https://biblio.ugent.be/publication/01GYFN90HPWM2QB65C77CEV6YCTest; http://hdl.handle.net/1854/LU-01GYFN90HPWM2QB65C77CEV6YCTest; http://doi.org/10.2217/fon-2022-0358Test; https://biblio.ugent.be/publication/01GYFN90HPWM2QB65C77CEV6YC/file/01HVP3KG2XTBEEXDW2SM489JR8Test

الإتاحة: https://doi.org/10.2217/fon-2022-0358Test
https://biblio.ugent.be/publication/01GYFN90HPWM2QB65C77CEV6YCTest
http://hdl.handle.net/1854/LU-01GYFN90HPWM2QB65C77CEV6YCTest
https://biblio.ugent.be/publication/01GYFN90HPWM2QB65C77CEV6YC/file/01HVP3KG2XTBEEXDW2SM489JR8Test

المؤلفون: Malorni, L, Tyekucheva, S, Hilbers, FS, Ignatiadis, M, Neven, P, Colleoni, M, Henry, S, Ballestrero, A, Bonetti, A, Jerusalem, G, Papadimitriou, K, Bernardo, A, Seles, E, Duhoux, FP, MacPherson, IR, Thomson, A, Davies, DM, Bergqvist, M, Migliaccio, I, Gebhart, G, Zoppoli, G, Bliss, JM, Benelli, M, McCartney, A, Kammler, R, De Swert, H, Ruepp, B, Fumagalli, D, Maibach, R, Cameron, D, Loi, S, Piccart, M, Regan, MM, International Breast Cancer Study Group, Breast International Group and PYTHIA Collaborators

المساهمون: Bliss, Judith

وصف الملف: application/pdf

العلاقة: European Journal of Cancer; https://repository.icr.ac.uk/handle/internal/4966Test

الإتاحة: https://repository.icr.ac.uk/handle/internal/4966Test

المؤلفون: Brenard, E., Dalenc, F., Filleron, T., Galant, C., Benest, A., Roché, H., Duhoux, Fp., Lacroix-Triki, M.

المساهمون: Société Française de Sénologie et de Pathologie Mammaire - SFSPM

المصدر: 35° Journées de la Société Française de Sénologie et de Pathologie Mammaire (SFSPM), Montpellier, 2013. Traitement personnalisé des cancers du sein : impact sur la prise en charge loco-régionale
https://hal.science/hal-03580362Test
35° Journées de la Société Française de Sénologie et de Pathologie Mammaire (SFSPM), Montpellier, 2013. Traitement personnalisé des cancers du sein : impact sur la prise en charge loco-régionale, Nov 2013, Montpellier, France. pp.374

مصطلحات موضوعية: [SDV.CAN]Life Sciences [q-bio]/Cancer

جغرافية الموضوع: Montpellier, France

العلاقة: hal-03580362; https://hal.science/hal-03580362Test; https://hal.science/hal-03580362/documentTest; https://hal.science/hal-03580362/file/bitstream_110656.pdfTest

الإتاحة: https://hal.science/hal-03580362Test
https://hal.science/hal-03580362/documentTest
https://hal.science/hal-03580362/file/bitstream_110656.pdfTest

المؤلفون: Howell, Sacha J, Campone, M, Cortes, J, Duhoux, FP, Ross, S, Morris, T, Franklin, S

المساهمون: Division of Cancer Sciences, The University of Manchester, Manchester, UK

العلاقة: https://dx.doi.org/10.1093/annonc/mdz242.036Test; Howell SJ, Campone M, Cortés J, Duhoux FP, Ross S, Morris T, et al. 341P Final results of the STEM trial: SFX-01 in the treatment and evaluation of ER+ Her2- metastatic breast cancer (mBC). Annals of Oncology. 2019;30(Supplement_5).; http://hdl.handle.net/10541/622613Test; Annals of Oncology

الإتاحة: https://doi.org/10.1093/annonc/mdz242.036Test
http://hdl.handle.net/10541/622613Test

المؤلفون: Piccart-Gebhart, MJ, Aftimos, PG, Duhoux, FP, Wildiers, H, Isambert, N, Campone, M, Tosi, D, Varga, AI, Boni, V, Doger, B, Corbacho, JG, Jimenez-Rodriguez, B, Borrego, MR, Saura, C, Arkenau, HT, Wardley, Andrew M, Troconiz, IF, Binaschi, M, Simonelli, C, Pellacani, AU

المساهمون: Institut Jules Bordet, Universit� Libre de Bruxelles, Brussels, Belgium

العلاقة: https://dx.doi.org/10.1200/JCO.2019.37.15_suppl.TPS1101Test; Piccart-Gebhart MJ, Aftimos PG, Duhoux FP, Wildiers H, Isambert N, Campone M, et al. B-PRECISE-01 Study: a phase Ib trial of MEN1611, a PI3K Inhibitor, combined with trastuzumab � fulvestrant for the treatment of HER2-positive advanced or metastatic breast cancer. J Clin Oncol. 2019;37(15_suppl):TPS1101-TPS.; http://hdl.handle.net/10541/622462Test; Journal of Clinical Oncology

الإتاحة: https://doi.org/10.1200/JCO.2019.37.15_suppl.TPS1101Test
http://hdl.handle.net/10541/622462Test